Peter Wulff

Biography

 Since receiving his Master of Science in Organic Chemistry in 1980, Mr Wulff has gained 34 years experience in the biotech and pharma industry, especially vaccines, neuroscience and patents. Peter joined A/S Ferrosan in 1981 and became the Head of Patent Department. In 1992, he became a European Patent Attorney. In 1989, he was a co-founder of NeuroSearch A/S May 1989, a Danish corporation listed on the Copenhagen Stock Exchange developing drugs acting on the central nervous system. Peter was the Director of Patents and Licensing and Corporate Management member of NeuroSearch A/S until 1997. Peter then moved to become (1994 - 2007) President & CEO of Bavarian Nordic A/S, a Danish corporation in vaccines listed on the Copenhagen Stock Exchange. Peter co-founded Sentinext Therapeutics Sdn Bhd in 2008 and was the CEO until 2013. He is currently an Independent Consultant to the Biotech industry and the Chairman of Skau Vaccines Aps and a Board member of InProTher Aps. Mr. Wulff also sits on the Advisory Board of the Veterinary Institute at the Danish Technical University.

Research Interest

 Biotechnology